These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

327 related articles for article (PubMed ID: 34143533)

  • 1. A review of significance of Aspergillus detection in airways of ICU COVID-19 patients.
    Pasquier G; Bounhiol A; Robert Gangneux F; Zahar JR; Gangneux JP; Novara A; Bougnoux ME; Dannaoui E
    Mycoses; 2021 Sep; 64(9):980-988. PubMed ID: 34143533
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aspergillus detection in airways of ICU COVID-19 patients: To treat or not to treat?
    Bounhiol A; Pasquier G; Novara A; Bougnoux ME; Dannaoui E
    J Mycol Med; 2022 Aug; 32(3):101290. PubMed ID: 35569323
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systematic screening for COVID-19 associated invasive aspergillosis in ICU patients by culture and PCR on tracheal aspirate.
    van Grootveld R; van Paassen J; de Boer MGJ; Claas ECJ; Kuijper EJ; van der Beek MT;
    Mycoses; 2021 Jun; 64(6):641-650. PubMed ID: 33606324
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Evaluation of risk factors for invasive pulmonary aspergillosis and detection of diagnostic values of galactomannan and PCR methods in bronchoalveolar lavage samples from non-neutropenic intensive care unit patients].
    Özger S; Hızel K; Kalkancı A; Aydoğdu M; Civil F; Dizbay M; Gürsel G
    Mikrobiyol Bul; 2015 Oct; 49(4):565-75. PubMed ID: 26649414
    [TBL] [Abstract][Full Text] [Related]  

  • 5. COVID-19 associated with pulmonary aspergillosis: A literature review.
    Lai CC; Yu WL
    J Microbiol Immunol Infect; 2021 Feb; 54(1):46-53. PubMed ID: 33012653
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mortality in critically ill patients with coronavirus disease 2019-associated pulmonary aspergillosis: A systematic review and meta-analysis.
    Singh S; Verma N; Kanaujia R; Chakrabarti A; Rudramurthy SM
    Mycoses; 2021 Sep; 64(9):1015-1027. PubMed ID: 34057252
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Invasive pulmonary aspergillosis in patients with acute respiratory syndrome by COVID-19.
    Sánchez Martín C; Madrid Martínez E; González Pellicer R; Armero Ibáñez R; Martínez González E; Llau Pitarch JV
    Rev Esp Anestesiol Reanim (Engl Ed); 2022 Jan; 69(1):48-53. PubMed ID: 35033481
    [TBL] [Abstract][Full Text] [Related]  

  • 8. COVID-19-associated pulmonary aspergillosis (CAPA): identification of Aspergillus species and determination of antifungal susceptibility profiles.
    Ozturk A; Bozok T; Erdogan M; Ibrahim BM; Bozok TS
    Folia Microbiol (Praha); 2023 Dec; 68(6):951-959. PubMed ID: 37294497
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SARS-CoV-2 and Aspergillus section Fumigati coinfection in an immunocompetent patient treated with corticosteroids.
    Sasoni N; Rodriguez Müller M; Posse G; González J; Leonardelli F; Garcia-Effron G
    Rev Iberoam Micol; 2021; 38(1):16-18. PubMed ID: 33500209
    [TBL] [Abstract][Full Text] [Related]  

  • 10. COVID-19-Associated Invasive Aspergillosis: Data from the UK National Mycology Reference Laboratory.
    Borman AM; Palmer MD; Fraser M; Patterson Z; Mann C; Oliver D; Linton CJ; Gough M; Brown P; Dzietczyk A; Hedley M; McLachlan S; King J; Johnson EM
    J Clin Microbiol; 2020 Dec; 59(1):. PubMed ID: 33087440
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical characteristics, radiologic findings, risk factors and outcomes of serum galactomannan-negative invasive pulmonary aspergillosis.
    Jung J; Kim MY; Chong YP; Lee SO; Choi SH; Kim YS; Woo JH; Kim SH
    J Microbiol Immunol Infect; 2018 Dec; 51(6):802-809. PubMed ID: 28712819
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Invasive pulmonary aspergillosis is associated with adverse clinical outcomes in critically ill patients receiving veno-venous extracorporeal membrane oxygenation.
    Rodriguez-Goncer I; Thomas S; Foden P; Richardson MD; Ashworth A; Barker J; Geraghty CG; Muldoon EG; Felton TW
    Eur J Clin Microbiol Infect Dis; 2018 Jul; 37(7):1251-1257. PubMed ID: 29623451
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Invasive pulmonary aspergillosis in critically ill patients with severe COVID-19 pneumonia: Results from the prospective AspCOVID-19 study.
    Lahmer T; Kriescher S; Herner A; Rothe K; Spinner CD; Schneider J; Mayer U; Neuenhahn M; Hoffmann D; Geisler F; Heim M; Schneider G; Schmid RM; Huber W; Rasch S
    PLoS One; 2021; 16(3):e0238825. PubMed ID: 33730058
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drivers and impact of antifungal therapy in critically ill patients with Aspergillus-positive respiratory tract cultures.
    Paiva JA; Mergulhão P; Gomes A; Taccone FS; Van den Abeele AM; Bulpa P; Misset B; Meersseman W; Dimopoulos G; Rello J; Vogelaers D; Blot S
    Int J Antimicrob Agents; 2017 Oct; 50(4):529-535. PubMed ID: 28669830
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of 1,3-β-d-glucan with galactomannan in serum and bronchoalveolar fluid for the detection of Aspergillus species in immunosuppressed mechanical ventilated critically ill patients.
    Lahmer T; Neuenhahn M; Held J; Rasch S; Schmid RM; Huber W
    J Crit Care; 2016 Dec; 36():259-264. PubMed ID: 27475024
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optimizing Antifungal Treatment Strategies to Prevent Invasive Pulmonary Aspergillosis Infection-Related Deaths in Intensive Care Unit Patients: The Need for Standardization of Research Definitions.
    Bassetti M; Vena A; Bavastro M; Giacobbe DR
    Mycopathologia; 2024 Jul; 189(4):69. PubMed ID: 39066809
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Review of influenza-associated pulmonary aspergillosis in ICU patients and proposal for a case definition: an expert opinion.
    Verweij PE; Rijnders BJA; Brüggemann RJM; Azoulay E; Bassetti M; Blot S; Calandra T; Clancy CJ; Cornely OA; Chiller T; Depuydt P; Giacobbe DR; Janssen NAF; Kullberg BJ; Lagrou K; Lass-Flörl C; Lewis RE; Liu PW; Lortholary O; Maertens J; Martin-Loeches I; Nguyen MH; Patterson TF; Rogers TR; Schouten JA; Spriet I; Vanderbeke L; Wauters J; van de Veerdonk FL
    Intensive Care Med; 2020 Aug; 46(8):1524-1535. PubMed ID: 32572532
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Invasive pulmonary aspergillosis in critically ill patients with COVID-19 in Australia: implications for screening and treatment.
    Tio SY; Williams E; Worth LJ; Deane AM; Bond K; Slavin MA; Sasadeusz J
    Intern Med J; 2021 Dec; 51(12):2129-2132. PubMed ID: 34939293
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Investigation of the value of precipitins in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) patients with a positive marker for Aspergillus species.
    Bellanger AP; Lallemand S; Tumasyan Horikian A; Navellou JC; Barrera C; Rouzet A; Scherer E; Reboux G; Piton G; Millon L
    Med Mycol; 2022 May; 60(5):. PubMed ID: 35604675
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multicenter evaluation of a lateral-flow device test for diagnosing invasive pulmonary aspergillosis in ICU patients.
    Eigl S; Prattes J; Lackner M; Willinger B; Spiess B; Reinwald M; Selitsch B; Meilinger M; Neumeister P; Reischies F; Wölfler A; Raggam RB; Flick H; Eschertzhuber S; Krause R; Buchheidt D; Thornton CR; Lass-Flörl C; Hoenigl M
    Crit Care; 2015 Apr; 19(1):178. PubMed ID: 25927915
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.